dapi has been researched along with Muscular Atrophy, Spinal in 2 studies
DAPI: RN given refers to parent cpd.
Muscular Atrophy, Spinal: A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattis, VB | 1 |
| Butchbach, ME | 1 |
| Lorson, CL | 2 |
| Wolstencroft, EC | 1 |
| Mattis, V | 1 |
| Bajer, AA | 1 |
| Young, PJ | 1 |
2 other studies available for dapi and Muscular Atrophy, Spinal
| Article | Year |
|---|---|
Detection of human survival motor neuron (SMN) protein in mice containing the SMN2 transgene: applicability to preclinical therapy development for spinal muscular atrophy.
Topics: Alternative Splicing; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Cells, Cultured; Disease | 2008 |
A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
Topics: Alanine; Amikacin; Amino Acid Substitution; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Mono | 2005 |